Results 1 to 10 of about 67,096 (237)

Unilateral Yasunari nodule-like appearance in a patient without neurofibromatosis type 1 [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine
Introduction: Yasunari nodules are choroidal lesions characterized by bright, poorly demarcated multiple lesions detected through near-infrared reflectance imaging and are considered diagnostic for neurofibromatosis type 1 (NF1).
Hamit Ali   +5 more
doaj   +2 more sources

Neurofibromatosis type I: points to be considered by general pediatricians [PDF]

open access: yesClinical and Experimental Pediatrics, 2021
Neurofibromatosis type 1 (NF1), a prevalent genetic disease that is transmitted in an autosomal dominant manner, is characterized by multiple cutaneous café-au-lait spots and neurofibromas as well as various degrees of neurological, skeletal, and ...
Eungu Kang, Hee Mang Yoon, Beom Hee Lee
doaj   +1 more source

Metastatic cluster 2-related pheochromocytoma/paraganglioma: a single-center experience and systematic review

open access: yesEndocrine Connections, 2021
Risk of metastatic disease in the cluster 2-related pheochromocytoma/paraganglioma (PPGL) is low. In MEN2 patients, identification of origin of met astases from pheochromocytoma (PCC) or medullary thyroid carcinoma (MTC) is challenging as both are of ...
Sandeep Kumar   +10 more
doaj   +1 more source

Ocular gamut of neurofibromatosis type 1

open access: yesKerala Journal of Ophthalmology, 2023
Background: Neurofibromatosis type 1 (NF1) is a multi-system autosomal dominant disorder affecting 1 in 3000 individuals. The diagnostic criteria of NF1 includes ocular manifestations.
Prathibha Shanthaveerappa   +3 more
doaj   +1 more source

Sporadic Metastatic Malignant Peripheral Nerve Sheath Tumour with an NF1 Mutation Responding to Trametinib: A Case Report

open access: yesCase Reports in Oncology, 2023
Sporadically occurring malignant peripheral nerve sheath tumours (MPNSTs) can have a variety of genomic alterations including altered NF1, leading to activation of the RAS-RAF-MEK-ERK signalling pathway. Trametinib is an inhibitor of MEK1 and MEK2.
Nadia Hitchen   +4 more
doaj   +1 more source

Childhood-Onset Refractory Hypertension Results from Neurofibromatosis Type 1 Caused by a Splicing NF1 Mutation

open access: yesKidney & Blood Pressure Research, 2023
Introduction: Neurofibromatosis type 1 (NF-1) is caused by mutations in the NF1 gene that encodes neurofibromin, a negative regulator of RAS proto-oncogene.
Yi-Ting Lu   +7 more
doaj   +1 more source

suz12 inactivation in p53- and nf1-deficient zebrafish accelerates the onset of malignant peripheral nerve sheath tumors and expands the spectrum of tumor types

open access: yesDisease Models & Mechanisms, 2020
Polycomb repressive complex 2 (PRC2) is an epigenetic regulator of gene expression that possesses histone methyltransferase activity. PRC2 trimethylates lysine 27 of histone H3 proteins (H3K27me3) as a chromatin modification associated with repressed ...
Felix Oppel   +8 more
doaj   +1 more source

The Spectrum of NF1 Gene Variations in Southeastern Turkey

open access: yesJournal of Pediatric Research, 2021
Aim:We aimed to expand the variant spectrum of the NF1 gene in Southeastern Turkey. Neurofibromatosis type 1 (NF1) disease is an inherited skin disorder with variable severity and heterogeneous systemic involvement.
Emre Kırat, Hatice Mutlu Albayrak
doaj   +1 more source

Extensive Plexiform Neurofibroma Presenting as Clitoromegaly in Neurofibromatosis Type 1

open access: yesJournal of Behçet Uz Children's Hospital, 2021
Neurofibromatosis type 1 (NF1) is an autosomal-dominant disorder with multisystem involvement. Genitourinary involvement of neurofibromatosis type 1 is rare condition and involvement of plexiform neurofibroma can cause painful clitoromegaly. A 9-year-old
Özlem Nalbantoğlu   +4 more
doaj   +1 more source

Germline genetic variants in pheochromocytoma/paraganglioma: single-center experience

open access: yesEndocrine Oncology, 2023
Pheochromocytoma and paragangliomas (PPGLs) are rare neuroendocrine tumors carrying 25–40% pathogenic germline gene variants (PGVs). We evaluated clinical, laboratory, and germline molecular profile of 115 patients with pathologic (14 patients were ...
José V Lima Jr   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy